JPY 1729.0
(0.93%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 23.44 Billion JPY | -15.94% |
2022 | 24.91 Billion JPY | -26.88% |
2021 | 34.48 Billion JPY | 15.86% |
2020 | 31.63 Billion JPY | 76.39% |
2019 | 19.24 Billion JPY | -4.32% |
2018 | 18.73 Billion JPY | 9.91% |
2017 | 18 Billion JPY | 0.76% |
2016 | 17.15 Billion JPY | -11.13% |
2015 | 20.06 Billion JPY | -5.26% |
2014 | 19.52 Billion JPY | -6.12% |
2013 | 20.78 Billion JPY | 26.71% |
2012 | 17.45 Billion JPY | 16.38% |
2011 | 15.1 Billion JPY | 13.39% |
2010 | 13.05 Billion JPY | 11.65% |
2009 | 11.74 Billion JPY | 14.6% |
2008 | 10.46 Billion JPY | -11.11% |
2007 | 11.81 Billion JPY | 12.88% |
2006 | 10.17 Billion JPY | 5.78% |
2005 | 9.92 Billion JPY | 7.42% |
2004 | 9.05 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -315 Million JPY | -103.11% |
2023 Q4 | 10.13 Billion JPY | 501.6% |
2023 Q3 | 1.68 Billion JPY | -77.87% |
2023 FY | - JPY | -15.94% |
2023 Q1 | 6.7 Billion JPY | -40.92% |
2023 Q2 | 7.6 Billion JPY | 13.4% |
2022 Q4 | 11.35 Billion JPY | 540.08% |
2022 FY | - JPY | -26.88% |
2022 Q1 | 6.31 Billion JPY | -42.37% |
2022 Q2 | 8.45 Billion JPY | 33.87% |
2022 Q3 | 1.77 Billion JPY | -79.01% |
2021 FY | - JPY | 15.86% |
2021 Q1 | 7.5 Billion JPY | -48.51% |
2021 Q4 | 10.95 Billion JPY | 43.28% |
2021 Q3 | 7.64 Billion JPY | -36.53% |
2021 Q2 | 12.04 Billion JPY | 60.49% |
2020 Q3 | 8.62 Billion JPY | 16.3% |
2020 Q1 | 2.3 Billion JPY | -70.67% |
2020 Q2 | 7.41 Billion JPY | 221.78% |
2020 FY | - JPY | 76.39% |
2020 Q4 | 14.57 Billion JPY | 68.94% |
2019 Q4 | 7.85 Billion JPY | 184.33% |
2019 Q2 | 7.27 Billion JPY | 852.49% |
2019 Q1 | 764 Million JPY | -92.28% |
2019 Q3 | 2.76 Billion JPY | -62.02% |
2019 FY | - JPY | -4.32% |
2018 Q2 | 5.54 Billion JPY | 305.93% |
2018 Q4 | 9.89 Billion JPY | 265.84% |
2018 FY | - JPY | 9.91% |
2018 Q1 | 1.36 Billion JPY | -83.75% |
2018 Q3 | 2.7 Billion JPY | -51.18% |
2017 Q3 | 4.07 Billion JPY | -7.05% |
2017 FY | - JPY | 0.76% |
2017 Q4 | 8.4 Billion JPY | 106.39% |
2017 Q2 | 4.38 Billion JPY | 389.39% |
2017 Q1 | 895 Million JPY | -90.25% |
2016 Q2 | 5 Billion JPY | 729.72% |
2016 Q3 | 4.22 Billion JPY | -15.48% |
2016 Q4 | 9.18 Billion JPY | 117.3% |
2016 FY | - JPY | -11.13% |
2016 Q1 | -794 Million JPY | -108.17% |
2015 Q3 | 4.09 Billion JPY | -11.75% |
2015 Q4 | 9.72 Billion JPY | 137.55% |
2015 FY | - JPY | -5.26% |
2015 Q2 | 4.63 Billion JPY | 239.53% |
2015 Q1 | 1.36 Billion JPY | -83.8% |
2014 Q4 | 8.43 Billion JPY | 74.64% |
2014 FY | - JPY | -6.12% |
2014 Q2 | 5.94 Billion JPY | 246.1% |
2014 Q3 | 4.82 Billion JPY | -18.82% |
2014 Q1 | 1.71 Billion JPY | -83.32% |
2013 Q1 | 2.64 Billion JPY | -62.63% |
2013 Q3 | 4.81 Billion JPY | 6.64% |
2013 Q2 | 4.51 Billion JPY | 70.55% |
2013 FY | - JPY | 26.71% |
2013 Q4 | 10.3 Billion JPY | 113.78% |
2012 FY | - JPY | 16.38% |
2012 Q4 | 7.08 Billion JPY | 76.8% |
2012 Q3 | 4 Billion JPY | 0.02% |
2012 Q2 | 4 Billion JPY | 61.48% |
2012 Q1 | 2.48 Billion JPY | -63.11% |
2011 FY | - JPY | 13.39% |
2011 Q4 | 6.72 Billion JPY | 107.62% |
2011 Q3 | 3.24 Billion JPY | -7.08% |
2011 Q2 | 3.48 Billion JPY | 110.88% |
2011 Q1 | 1.65 Billion JPY | -70.89% |
2010 FY | - JPY | 11.65% |
2010 Q3 | 2.49 Billion JPY | -30.15% |
2010 Q2 | 3.56 Billion JPY | 145.12% |
2010 Q1 | 1.45 Billion JPY | -65.1% |
2010 Q4 | 5.68 Billion JPY | 127.92% |
2009 Q4 | 4.17 Billion JPY | 51.54% |
2009 FY | - JPY | 14.6% |
2009 Q3 | 2.75 Billion JPY | -21.88% |
2009 Q1 | 1.48 Billion JPY | -61.94% |
2009 Q2 | 3.52 Billion JPY | 136.83% |
2008 FY | - JPY | -11.11% |
2008 Q4 | 3.91 Billion JPY | 176.91% |
2008 Q2 | 1.62 Billion JPY | 0.0% |
2008 Q3 | 1.41 Billion JPY | -13.11% |
2007 FY | - JPY | 12.88% |
2006 FY | - JPY | 5.78% |
2005 FY | - JPY | 7.42% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | -2801.666% |
Seikagaku Corporation | 2.09 Billion JPY | -1018.559% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | -310.955% |
Create Medic Co., Ltd. | 1.39 Billion JPY | -1585.003% |
PHC Holdings Corporation | 39.08 Billion JPY | 40.018% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | -1100.327% |
Rion Co., Ltd. | 4.37 Billion JPY | -435.678% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 35.292% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | -89.225% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | -616.247% |
3-D Matrix, Ltd. | 2.09 Billion JPY | -1020.698% |
CYBERDYNE Inc. | -2 Million JPY | 1172350.0% |